Bipartisan Senators Propose Reforms to 340B Drug Pricing Program
A bipartisan group of U.S. senators has introduced a bill to reform the 340B drug pricing program, which provides discounted drugs to healthcare providers serving low-income populations. The proposed legislation aims to establish new transparency and reporting requirements to ensure that the program's benefits reach patients rather than being retained by hospitals. The bill is supported by Senators Jerry Moran, Tammy Baldwin, Shelley Moore Capito, Tim Kaine, John Boozman, and John Hickenlooper. The reform efforts come amid ongoing debates between pharmaceutical companies and hospitals over the program's scope and implementation. While the bill seeks to preserve the program's critical benefits, some critics argue that it does not impose sufficient restrictions. 
